Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Man Group plc

Man Group plc trimmed its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 22.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 905,972 shares of the health services provider's stock after selling 266,544 shares during the period. Man Group plc owned 0.53% of Teladoc Health worth $8,235,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of TDOC. Maple Rock Capital Partners Inc. raised its holdings in shares of Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after purchasing an additional 2,331,000 shares during the period. Vanguard Group Inc. raised its holdings in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the period. Renaissance Technologies LLC raised its holdings in shares of Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after purchasing an additional 763,265 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Stock Performance

NYSE:TDOC opened at $7.31 on Tuesday. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average of $7.55 and a 200-day moving average of $9.35. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -1.27 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Stifel Nicolaus dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Piper Sandler dropped their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group dropped their price objective on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Finally, Royal Bank of Canada increased their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Twelve equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Teladoc Health has a consensus rating of "Hold" and an average target price of $9.71.

Insiders Place Their Bets

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.58% of the company's stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.